Literature DB >> 22290867

SFRP1 and SFRP2 dose-dependently regulate midbrain dopamine neuron development in vivo and in embryonic stem cells.

Julianna Kele1, Emma R Andersson, J Carlos Villaescusa, Lukas Cajanek, Clare L Parish, Sonia Bonilla, Enrique M Toledo, Vitezslav Bryja, Jeffrey S Rubin, Akihiko Shimono, Ernest Arenas.   

Abstract

Secreted Frizzled related proteins (sFRPs) are a family of proteins that modulate Wnt signaling, which in turn regulates multiple aspects of ventral midbrain (VM) and dopamine (DA) neuron development. However, it is not known which Wnt signaling branch and what aspects of midbrain DA neuron development are regulated by sFRPs. Here, we show that sFRP1 and sFRP2 activate the Wnt/planar-cell-polarity/Rac1 pathway in DA cells. In the developing VM, sFRP1 and sFRP2 are expressed at low levels, and sFRP1-/- or sFRP2-/- mice had no detectable phenotype. However, compound sFRP1-/-;sFRP2-/- mutants revealed a Wnt/PCP phenotype similar to that previously described for Wnt5a-/- mice. This included an anteroposterior shortening of the VM, a lateral expansion of the Shh domain and DA lineage markers (Lmx1a and Th), as well as an accumulation of Nurr1+ precursors in the VM. In vitro experiments showed that, while very high concentrations of SFRP1 had a negative effect on cell survival, low/medium concentrations of sFRP1 or sFRP2 promoted the DA differentiation of progenitors derived from primary VM cultures or mouse embryonic stem cells (ESCs), mimicking the effects of Wnt5a. We thus conclude that the main function of sFRP1 and sFRP2 is to enhance Wnt/PCP signaling in DA cells and to regulate Wnt/PCP-dependent functions in midbrain development. Moreover, we suggest that low-medium concentrations of sFRPs may be used to enhance the DA differentiation of ESCs and improve their therapeutic application.
Copyright © 2012 AlphaMed Press.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22290867      PMCID: PMC6993144          DOI: 10.1002/stem.1049

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  56 in total

1.  Interactions of Wnt/beta-catenin signaling and sonic hedgehog regulate the neurogenesis of ventral midbrain dopamine neurons.

Authors:  Mianzhi Tang; J Carlos Villaescusa; Sarah X Luo; Camilla Guitarte; Simonia Lei; Yasunori Miyamoto; Makoto M Taketo; Ernest Arenas; Eric J Huang
Journal:  J Neurosci       Date:  2010-07-07       Impact factor: 6.167

2.  Wnt-5a induces Dishevelled phosphorylation and dopaminergic differentiation via a CK1-dependent mechanism.

Authors:  Vítezslav Bryja; Gunnar Schulte; Nina Rawal; Alexandra Grahn; Ernest Arenas
Journal:  J Cell Sci       Date:  2007-01-23       Impact factor: 5.285

Review 3.  Wnt signaling in neural circuit assembly.

Authors:  Patricia C Salinas; Yimin Zou
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

4.  The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain.

Authors:  A P McMahon; A Bradley
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

5.  SARPs: a family of secreted apoptosis-related proteins.

Authors:  H S Melkonyan; W C Chang; J P Shapiro; M Mahadevappa; P A Fitzpatrick; M C Kiefer; L D Tomei; S R Umansky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

6.  Beta-arrestin and casein kinase 1/2 define distinct branches of non-canonical WNT signalling pathways.

Authors:  Vítĕzslav Bryja; Alexandra Schambony; Lukás Cajánek; Isabel Dominguez; Ernest Arenas; Gunnar Schulte
Journal:  EMBO Rep       Date:  2008-10-24       Impact factor: 8.807

7.  Sfrp1 and Sfrp2 are required for normal male sexual development in mice.

Authors:  Nick Warr; Pam Siggers; Debora Bogani; Rachel Brixey; Laura Pastorelli; Laura Yates; Charlotte H Dean; Sara Wells; Wataru Satoh; Akihiko Shimono; Andy Greenfield
Journal:  Dev Biol       Date:  2008-12-07       Impact factor: 3.582

8.  Soluble frizzled-related protein 1 is estrogen inducible in bone marrow stromal cells and suppresses the earliest events in lymphopoiesis.

Authors:  Takafumi Yokota; Kenji Oritani; Karla P Garrett; Taku Kouro; Makoto Nishida; Isao Takahashi; Michiko Ichii; Yusuke Satoh; Paul W Kincade; Yuzuru Kanakura
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

9.  Effects of Wnt1 signaling on proliferation in the developing mid-/hindbrain region.

Authors:  Markus Panhuysen; Daniela M Vogt Weisenhorn; Veronique Blanquet; Claude Brodski; Ulrich Heinzmann; Wolfgang Beisker; Wolfgang Wurst
Journal:  Mol Cell Neurosci       Date:  2004-05       Impact factor: 4.314

10.  Wnt5a regulates midbrain dopaminergic axon growth and guidance.

Authors:  Brette D Blakely; Christopher R Bye; Chathurini V Fernando; Malcolm K Horne; Maria L Macheda; Steven A Stacker; Ernest Arenas; Clare L Parish
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

View more
  30 in total

1.  Wnts Are Expressed in the Ependymal Region of the Adult Spinal Cord.

Authors:  Carlos Gonzalez-Fernandez; Angel Arevalo-Martin; Beatriz Paniagua-Torija; Isidro Ferrer; Francisco J Rodriguez; Daniel Garcia-Ovejero
Journal:  Mol Neurobiol       Date:  2016-10-08       Impact factor: 5.590

Review 2.  Wnt signaling: role in Alzheimer disease and schizophrenia.

Authors:  Nibaldo C Inestrosa; Carla Montecinos-Oliva; Marco Fuenzalida
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-18       Impact factor: 4.147

3.  Secreted Frizzled-related protein 1 (sFRP1) regulates spermatid adhesion in the testis via dephosphorylation of focal adhesion kinase and the nectin-3 adhesion protein complex.

Authors:  Elissa W P Wong; Will M Lee; C Yan Cheng
Journal:  FASEB J       Date:  2012-10-16       Impact factor: 5.191

4.  BMP and TGF-β pathway mediators are critical upstream regulators of Wnt signaling during midbrain dopamine differentiation in human pluripotent stem cells.

Authors:  Jingli Cai; Stephanie Schleidt; Joshua Pelta-Heller; Danielle Hutchings; Gregory Cannarsa; Lorraine Iacovitti
Journal:  Dev Biol       Date:  2013-01-23       Impact factor: 3.582

5.  Acute Simian Varicella Virus Infection Causes Robust and Sustained Changes in Gene Expression in the Sensory Ganglia.

Authors:  Nicole Arnold; Thomas Girke; Suhas Sureshchandra; Ilhem Messaoudi
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

6.  Methylation of secreted frizzled-related protein 1 (SFRP1) promoter downregulates Wnt/β-catenin activity in keloids.

Authors:  Jiaqi Liu; Huayu Zhu; Hongtao Wang; Jun Li; Fu Han; Yang Liu; Wanfu Zhang; Ting He; Na Li; Zhao Zheng; Dahai Hu
Journal:  J Mol Histol       Date:  2018-02-17       Impact factor: 2.611

7.  Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia.

Authors:  Pavlina Janovska; Lucie Poppova; Karla Plevova; Hana Plesingerova; Martin Behal; Marketa Kaucka; Petra Ovesna; Michaela Hlozkova; Marek Borsky; Olga Stehlikova; Yvona Brychtova; Michael Doubek; Michaela Machalova; Sivasubramanian Baskar; Alois Kozubik; Sarka Pospisilova; Sarka Pavlova; Vitezslav Bryja
Journal:  Clin Cancer Res       Date:  2015-08-03       Impact factor: 12.531

8.  Novel insights into embryonic stem cell self-renewal revealed through comparative human and mouse systems biology networks.

Authors:  Karen G Dowell; Allen K Simons; Hao Bai; Braden Kell; Zack Z Wang; Kyuson Yun; Matthew A Hibbs
Journal:  Stem Cells       Date:  2014-05       Impact factor: 6.277

9.  The Wnt/Ca2+ pathway is involved in interneuronal communication mediated by tunneling nanotubes.

Authors:  Jessica Y Vargas; Frida Loria; Yuan-Ju Wu; Gonzalo Córdova; Takashi Nonaka; Sebastien Bellow; Sylvie Syan; Masato Hasegawa; Geeske M van Woerden; Capucine Trollet; Chiara Zurzolo
Journal:  EMBO J       Date:  2019-10-18       Impact factor: 11.598

Review 10.  Translation of WNT developmental programs into stem cell replacement strategies for the treatment of Parkinson's disease.

Authors:  Enrique M Toledo; Daniel Gyllborg; Ernest Arenas
Journal:  Br J Pharmacol       Date:  2017-07-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.